"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19

FMH College of Medicine and Dentistry

Status

Completed

Conditions

COVID-19 Pneumonia

Treatments

Combination Product: Patients with COVID-19 Pneumonia

Study type

Observational

Funder types

Other

Identifiers

NCT05249803

FMH-27/12/2021-IRB-983

Details and patient eligibility

About

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic.

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Full description

Material & Methods:

Study design: Retrospective study. Study Settings: Study was conducted in Fatima Memorial Hospital, Lahore. Study Duration: Study was conducted on Covid-19 patients who were admitted from March 2021 to August 2021.

Enrollment

133 patients

Sex

All

Ages

16 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Critically sick patients with COVID-19 Pneumonia
All admitted ICU patients with a diagnosis of COVID-19 pneumonia
Patients having positive reverse transcriptase PCR for COVID-19
Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury
All patients above 16 years of age with both genders( males and females)

Exclusion criteria